Gary McIntosh
Impact in
- Oncology top 10%
- Cancer-related Molecular Pathways
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Oncology 3
- Cancer-related Molecular Pathways 3
- Co-authors
- Ian D. Milton (3 shared papers)C. H. W. Horne (2 shared papers)T.W.J. Lennard (2 shared papers)James Anderson (2 shared papers)James A. Henry (2 shared papers)Michael Steward (1 shared paper)Brian Angus (1 shared paper)Charles H. W. Horne (3 shared papers)
- Journals
- Journal of Clinical Pathology (1 paper)British Journal of Haematology (1 paper)American Journal Of Pathology (1 paper)Journal of Neuropathology & Experimental Neurology (1 paper)The Journal of Pathology (1 paper)
- Partner nations
- United KingdomCanada
In The Last Decade
Gary McIntosh
9 papers receiving 484 citations
Peers
Comparison fields: 5 of 70
- Oncology 249
- Genetics 75
- Pathology and Forensic Medicine 72
- Biotechnology 33
- Hematology 40
Countries citing papers authored by Gary McIntosh
This map shows the geographic impact of Gary McIntosh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary McIntosh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary McIntosh more than expected).
Fields of papers citing papers by Gary McIntosh
This network shows the impact of papers produced by Gary McIntosh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary McIntosh. The network helps show where Gary McIntosh may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary McIntosh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Determination of the prognostic value of cyclin D1 overexpression in breast cancer. | 1995 | 187 |
| 2 | 1999 | 115 | |
| 3 | 2009 | 56 | |
| 4 | 2012 | 43 | |
| 5 | 2008 | 35 | |
| 6 | 1996 | 24 | |
| 7 | 1997 | 19 | |
| 8 | 2007 | 7 | |
| 9 | 2004 | 5 |
About Gary McIntosh
Gary McIntosh is a scholar working on Molecular Biology, Oncology, Genetics, Neurology and Physiology, having authored 9 papers that have together received 491 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (3 papers), Alzheimer's disease research and treatments (2 papers), Parkinson's Disease Mechanisms and Treatments (2 papers), Cell Adhesion Molecules Research (2 papers), Lymphoma Diagnosis and Treatment (1 paper), Prostate Cancer Treatment and Research (1 paper), Chronic Myeloid Leukemia Treatments (1 paper) and Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper). The work is most often cited by research in Oncology (249 citations), Genetics (75 citations), Pathology and Forensic Medicine (72 citations), Biotechnology (33 citations) and Hematology (40 citations). Gary McIntosh has collaborated with scholars based in United Kingdom and Canada. Frequent co-authors include Ian D. Milton, C. H. W. Horne, T.W.J. Lennard, James Anderson, James A. Henry, Michael Steward, Brian Angus, Charles H. W. Horne, Brian Angus and Andrew J. Lodge. Their work appears in journals such as Journal of Clinical Pathology, British Journal of Haematology, American Journal Of Pathology, Journal of Neuropathology & Experimental Neurology and The Journal of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.